brain target
DESCRIPTION
Brain TargetTRANSCRIPT
![Page 2: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/2.jpg)
We create software to estimate efficiency of neurosurgical operations
![Page 3: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/3.jpg)
Facts & Statistics
6.6
6.9
Canada
2009 2013
New: 2900 ppl/year
6.5
7.3USA
2009 2013
Sick: 138 054 pplNew: 24 620 ppl/year
6.5
Russia
2010
22.5
China
2010
Sick: 76 239 ppl
According to:
![Page 4: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/4.jpg)
![Page 5: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/5.jpg)
conclusion
![Page 6: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/6.jpg)
Customers: neurosurgery institutions (60 in Russia), insurance companies
50 000 operations annually
Market: 30 billions rubles
Our price: 1500 rubles per patient
Income: 1 year: 25M, 2 year: 50M, 3 year: 125M(values are in rubles)
![Page 7: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/7.jpg)
Potential Customers
InternationalMarket
![Page 8: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/8.jpg)
It is simple, precise, reliable.
![Page 9: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/9.jpg)
It is simple, precise, reliable.
![Page 10: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/10.jpg)
Competitive advantages
Property Our product DICOM Viewers( eFilm, OsiriX, etc. )
Automaticity +++ +
Accuracy +++ +
Simplicity +++ +
Specificity +/- -/+
Open-Source - +
Type of application Web service & Standalone Standalone
![Page 11: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/11.jpg)
Our Team
Alexey Krivoshapkin
R&D DirectorМ. D. Med. , Professor, Corresponding Member of RAMS, Chief of Angioneurology and Neurosurgery Center, Аcademician E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology. Chairman of Neurosurgical Department, Novosibirsk State Medical University. FRCS of England.
Gleb Sergeev
Co-founder, algorithm’s developer
Leonid Kalneus
Co-founder, software engineer
![Page 12: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/12.jpg)
Today’s status
1. 5 publications (1 in English)
2. Software prototype
3. Patent
![Page 13: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/13.jpg)
Requirements
First year – 1M rubles
Development45%
Testing15%
Research5%
Advertisement34%
Other 1%Development
28%
Research25%
Advertisement46%
Other1%
Second year – 4M rubles
![Page 14: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/14.jpg)
Our Partners:
Novosibirsk Research Institute of Circulation Pathology Academician E.N.Meshalkina
Speaker: Gleb Sergeev Email: [email protected]
Thank you for your attention!Q&A
![Page 15: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/15.jpg)
Publications1.Сергеев Г. С., Орлов К. Ю., Кривошапкин А. Л. и др. Программное обеспечение для оценки степени деваскуляризации артериовенозных мальформаций. /Патология кровообращения и кардиохирургия. 2013. № 1. С. 25-28.
2.Кривошапкин А. Л., Панарин В. А., Орлов К. Ю. и др. Алгоритм предупреждения гемодинамических кровоизлияний при эмболизации церебральных артерио-венозных мальформаций./ "Бюллетень Сибирского отделения Российской академии медицинских наук» №6, 2013
3.Кривошапкин А. Л., Сергеев Г. С., Гайтан А. С. И др. Новый программный метод объективной оценки степени резекции глиобластомы головного мозга. / «Вопросы нейрохирургии» имени Н.Н. Бурденко» - статья получила положительный отзыв у рецензента
4. Сергеев Г. С., Курбатов В. П., Орлов К. Ю. и др. Алгоритм вычисления остаточного объема артериовенозной мальформации после эндоваскулярной эмболизации./ «Радиология — практика» - публикуется май-июнь 2014.
5. New Software to Standardize the Assessment of Cerebral Arteriovenous Malformations Embolization Degree. Krivoshapkin, A. Gaytan, G. Sergeev. Congress e-poster. 15thWFNS World Congress, 9-13.09.2013Seoul, Korea
15
![Page 16: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/16.jpg)
Patent
![Page 17: Brain Target](https://reader033.vdocuments.net/reader033/viewer/2022042714/55621b10d8b42acb1e8b54ac/html5/thumbnails/17.jpg)
Feedback